Sec Form 4 Filing - Sutaria Saumya @ TENET HEALTHCARE CORP - 2022-02-24

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Sutaria Saumya
2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
CEO
(Last) (First) (Middle)
14201 DALLAS PARKWAY
3. Date of Earliest Transaction (MM/DD/YY)
02/24/2022
(Street)
DALLAS, TX75254
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock( 1 ) 02/24/2022 M 25,228 A 287,914 D
Common Stock 02/24/2022 F 12,509( 3 ) D $ 81.2 275,405 D
Common Stock( 4 ) 02/25/2022 M 47,962 A 323,367 D
Common Stock 02/25/2022 F 23,780( 3 ) D $ 85.71 299,587 D
Common Stock( 5 ) 02/25/2022 M 47,181 A 346,768 D
Common Stock 02/25/2022 F 23,393( 3 ) D $ 85.71 323,375 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
2021 February Restricted Stock Units ( 1 ) 02/24/2022 M 25,228 ( 1 ) ( 1 ) Common Stock( 6 ) 25,228 $ 0 50,458 D
2020 February Restricted Stock Units ( 4 ) 02/25/2022 M 47,962 ( 4 ) ( 4 ) Common Stock( 6 ) 47,962 $ 0 47,962 D
2019 February Restricted Stock Units ( 5 ) 02/25/2022 M 47,181 ( 5 ) ( 5 ) Common Stock( 6 ) 47,181 $ 0 0 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Sutaria Saumya
14201 DALLAS PARKWAY
DALLAS, TX75254
X CEO
Signatures
Chad J. Wiener, as Attorney-in-Fact for Saumya Sutaria 02/28/2022
Signature of Reporting Person Date
Explanation of Responses:
( 1 )As previously reported, on February 24, 2021, the reporting person received a grant of 75,686 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 24, 2022, resulting in the vesting and settlement of 25,228 shares of common stock, as shown in Table I. The remaining 50,458 restricted stock units are shown in Table II, of which 25,229 are scheduled to vest on each of February 24, 2023, and February 24, 2024.
( 2 )Restricted stock units convert into common stock on a one-for-one basis.
( 3 )Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
( 4 )As previously reported, on February 26, 2020, the reporting person received a grant of 143,885 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 47,961 shares of common stock. The second anniversary occurred on February 25, 2022 (the business day prior to February 26, 2022, which fell on a weekend), resulting in the vesting and settlement of 47,962 shares of common stock, as shown in Table I. The remaining 47,962 restricted stock units are shown in Table II, and are scheduled to vest on February 26, 2023.
( 5 )As previously reported, on February 27, 2019, the reporting person received a grant of 141,543 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 47,181 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 47,181 shares of common stock. The third anniversary occurred on February 25, 2022 (the business day prior to February 27, 2022, which fell on a weekend), resulting in the vesting and settlement of 47,181 shares of common stock, as shown in Table I.
( 6 )Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.